These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5084851)

  • 1. [Experimental chemotherapy].
    Prát V
    Cas Lek Cesk; 1972 Nov; 111(45):1053-4. PubMed ID: 5084851
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular biology aspects of the antimicrobial effect of synthetic chemotherapeutic agents].
    Popov N
    Z Arztl Fortbild (Jena); 1982 Aug; 76(15):662-6. PubMed ID: 7150403
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary tract infections in the involutive age. 2].
    Migliori V; Londei M; Bonazzi A; Cavaciocchi P; Cuppini S
    G Clin Med; 1981 Aug; 62(8):585-90. PubMed ID: 7308641
    [No Abstract]   [Full Text] [Related]  

  • 4. [Laboratory control of chemotherapy].
    Zahradnický J
    Cas Lek Cesk; 1972 Nov; 111(45):1050-2. PubMed ID: 4484657
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotics.
    Hedley D; Matts SG
    Br J Clin Pract; 1974 Jun; 28(6):193-6. PubMed ID: 4447765
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of bacillary dysentery].
    Gioieni A
    Clin Ter; 1980 Jan; 92(2):197-80. PubMed ID: 7389276
    [No Abstract]   [Full Text] [Related]  

  • 7. Piromidic acid and beta-hydroxypiromidic acid: therapeutic effectiveness on experimental E. coli pyelonephritis in the rat.
    Loew H; Ritzerfeld W
    Int J Clin Pharmacol; 1973 Apr; 7(2):234-7. PubMed ID: 4581342
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of animal experiments for antibcterial therapy of infection of the urinary tract in man].
    Prát V; Konícková L
    Cas Lek Cesk; 1971 Sep; 110(39):909-13. PubMed ID: 5098273
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host resistance to intracellular parasites and its influence on the efficacy of antibiotic therapy.
    Hormaeche CE
    J Chemother; 1989 Jul; 1(4 Suppl):413-5. PubMed ID: 16312463
    [No Abstract]   [Full Text] [Related]  

  • 11. [New therapeutic possibility in severe gram negative bacillus infections].
    Schortgen G; Tancrede C; Goulon M
    Therapeutique; 1973 Dec; 49(10):699-702. PubMed ID: 4792641
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiological, etiologic and therapeutic aspects of urinary tract infections in children. Study of 137 cases].
    Popescu V; Arion C; Dragomir D; Georgescu M; Vlăsceanu S; Popescu A; Spătaru L; Truşcă G; Vasilescu MI; Vişinescu GM
    Rev Pediatr Obstet Ginecol Pediatr; 1982; 31(2):163-82. PubMed ID: 6815762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interdisciplinary meeting on anti-infection chemotherapy. 5 December 1985, Paris].
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):549-698. PubMed ID: 3534740
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current treatment of gonorrhea].
    Szarmach H
    Pol Tyg Lek; 1969 Aug; 24(32):1250-3. PubMed ID: 4900635
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of Voren on the progress of experimental bacterial infections and their therapy using antibiotics and sulfonamides as well as on the phagocytosis activity of the reticuloendothelial system (RES) and on the serum protein composition in mice].
    Goeth H; Lechner U
    Berl Munch Tierarztl Wochenschr; 1978 Mar; 91(5):87-93. PubMed ID: 637833
    [No Abstract]   [Full Text] [Related]  

  • 16. [How to prescribe antibiotics in urinary infections in infants and children].
    Clément R
    Presse Med (1893); 1969 Dec; 77(53):2003-5. PubMed ID: 5369442
    [No Abstract]   [Full Text] [Related]  

  • 17. Selecting therapeutic concentrations: minimum inhibitory concentrations vs subminimum or supraminimum inhibitory concentrations.
    Powers TE; Varma KJ; Powers JD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1062-7. PubMed ID: 6392231
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
    Kuck NA; Petersen PJ; Weiss WJ; Jacobus NV; Testa RT; Tally FP
    J Chemother; 1989 Jul; 1(4 Suppl):105-6. PubMed ID: 16312325
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assessment of the correctness of the diagnosis and treatment of subjects hospitalized for urinary tract infections in clinics and hospitals].
    Varese LA; Girazioli F; Tapparo D; Viretto A; Antoniola P
    Minerva Pediatr; 1982 Feb; 34(3):77-82. PubMed ID: 6978991
    [No Abstract]   [Full Text] [Related]  

  • 20. Pefloxacin--a laboratory and clinical evaluation of a new quinolone. Based on papers presented at the 14th International Congress of Chemotherapy. Kyoto, Japan, June 1985.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-118. PubMed ID: 3458695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.